SCOPUS 정보 검색 플랫폼

Acta Oncologica

Volumn 43, Issue 6, 2004, Pages 592-593

Complete sustained regression of extensive psoriasis with cetuximab combination chemotherapy [1]

(3) Trivin, Florence a Boucher, Eveline a Raoul, Jean Luc a

a CENTRE EUGÈNE MARQUIS (France)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CORTICOSTEROID; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; KERATOLYTIC AGENT;

ACNE; AGED; BACK; CASE REPORT; COLON CANCER; COMBINATION CHEMOTHERAPY; DRUG INFUSION; DRUG WITHDRAWAL; ELBOW; EYELASH; FACE; FOLLOW UP; FOREARM; HUMAN; LEG; LETTER; MALE; METASTASIS; NECK; PAPULAR SKIN DISEASE; PARONYCHIA; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; REMISSION; SEBORRHEIC DERMATITIS; SIDE EFFECT; ULTRAVIOLET B RADIATION;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; HUMANS; MALE; PSORIASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 4844220384 PISSN: 0284186X EISSN: None Source Type: Journal
DOI: 10.1080/02841860410020211 Document Type: Letter

Times cited : (19)

References (8)

1
- 0029932419
- Targeting the epidermal growth factor receptor for therapy of carcinomas
- Davies DE, Chamberlin SG. Targeting the epidermal growth factor receptor for therapy of carcinomas. Biochem Pharmacol 1996; 51: 1101-10.
- (1996) Biochem Pharmacol , vol.51 , pp. 1101-1110
- Davies, D.E.¹ Chamberlin, S.G.²

2
- 0037010077
- Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody
- Needle MN. Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody. Semin Oncol 2002; 29(Suppl 14): 55-60.
- (2002) Semin Oncol , vol.29 , Issue.14 SUPPL. , pp. 55-60
- Needle, M.N.¹

3
- 0038163630
- Epidermal growth factor receptor inhibition induces trichomegaly
- Dueland S, Sauer T, Lund-Johansen F, Ostenstad B, Tveit KM. Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncol 2003; 42(4): 345-6.
- (2003) Acta Oncol , vol.42 , Issue.4 , pp. 345-346
- Dueland, S.¹ Sauer, T.² Lund-Johansen, F.³ Ostenstad, B.⁴ Tveit, K.M.⁵

4
- 0344773402
- The presence and intensity of the cetuximab-induced acne-like rash increased survival in studies across multiple malignacies
- Proceedings of ASCO annual meeting Abstract 871
- Salt L, Abbruzzese JL, Arzania M, Needle M. The presence and intensity of the cetuximab-induced acne-like rash increased survival in studies across multiple malignacies. J Clin Oncol, Proceedings of ASCO annual meeting 2003, Abstract 871.
- (2003) J Clin Oncol
- Salt, L.¹ Abbruzzese, J.L.² Arzania, M.³ Needle, M.⁴

5
- 0025300071
- The EGF/TGF alpha receptor in skin
- King LE Jr, Gates RE, Stoscheck CM, Nanney LB. The EGF/TGF alpha receptor in skin. J Invest Dermatol 1990; 94(Suppl 6): 164S-70S.
- (1990) J Invest Dermatol , vol.94 , Issue.6 SUPPL.
- King Jr., L.E.¹ Gates, R.E.² Stoscheck, C.M.³ Nanney, L.B.⁴

6
- 0029743002
- Cell kinetic characterization of cultured human keratinocytes from normal and psoriatic individuals
- Van Ruissen F, de Jongh GJ, van Erp PE, Boezeman JB, Schalkwijk J. Cell kinetic characterization of cultured human keratinocytes from normal and psoriatic individuals. J Cell Physiol 1996; 168: 684-94.
- (1996) J Cell Physiol , vol.168 , pp. 684-694
- Van Ruissen, F.¹ De Jongh, G.J.² Van Erp, P.E.³ Boezeman, J.B.⁴ Schalkwijk, J.⁵

7
- 0025244363
- Epidermal growth factor/transforming growth factor alpha receptors and psoriasis
- King LE Jr, Gates RE, Stoscheck CM, Nanney LB. Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. J Invest Dermatol 1990; 95: 10S-2S.
- (1990) J Invest Dermatol , vol.95
- King Jr., L.E.¹ Gates, R.E.² Stoscheck, C.M.³ Nanney, L.B.⁴

8
- 0034131327
- Inhibitors of tyrosine kinases in the treatment of psoriasis
- Ben-Bassat H, Klein BY. Inhibitors of tyrosine kinases in the treatment of psoriasis. Curr Pharm Des 2000; 6: 933-42.
- (2000) Curr Pharm des , vol.6 , pp. 933-942
- Ben-Bassat, H.¹ Klein, B.Y.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.